BRF S.A. - Q1 FY2026 Earnings Analysis

Performance Highlights

BRF reported Q1 2026 net revenue of R$15,327 million, down 1.2% year-over-year, as a 1.8% decline in total volume to 1,220 thousand tons was only partially offset by a 0.6% improvement in average price to R$12.56 per kilogram. Adjusted EBITDA contracted 10.0% to R$2,477 million with a margin of 16.2%, down 1.6 percentage points versus Q1 2025, while net income fell 54.5% to R$539 million as net financial expenses surged 48.4% to R$679 million.

Gross margin compressed 1.9 percentage points to 24.2% as unit COGS rose 3.2% year-over-year, driven by product mix shifts toward beef cuts under the Marfrig integration, inflationary pressure on freight and labor, and higher integrated farmer compensation, effects only partially mitigated by grain cost declines of 10.9% for corn and 8.5% for soybean meal. External markets showed resilience, with volume rising 1.0% and 35 new export authorizations secured across the EU, South America, and Asia, while the GCC region delivered its strongest-ever Ramadan campaign in sales volume under the Sadia brand.

Management Outlook and Forward Catalysts

Management highlighted the ongoing Marfrig-BRF integration, including the rollout of a unified protein sales force, as a structural efficiency lever expected to generate sustained capillarity and distribution gains across the beef and poultry portfolio. The Company's first EU chicken protein shipments following October 2025 pre-listing approval signal meaningful market access expansion, while net debt declined R$272 million sequentially to R$9,122 million, underscoring continued deleveraging momentum.

The central investor debate heading into Q2 2026 centers on whether margin recovery is achievable as BRL appreciation continues to compress export realization and domestic protein prices remain soft, pressuring integrated farmer margins. Bulls will watch for accelerating EU export volumes, grain cost tailwinds, and MBRF+ efficiency program delivery, while bears will monitor Turkey's persistent supply-demand imbalance, elevated financial expenses, and execution risk in the Marfrig synergy integration.